This work was supported by The Fox Chase Cancer Center Board of Directors (DDM), the American Society of Hematology Scholar Award (SMS), American Cancer Society RSG (SMS) and the Department of Defense (Award#: W81XWH-18-1-0472).

All of the animal procedures described in this protocol have been approved by the Institutional Animal Care and Use committee (IACUC) at Fox Chase Cancer Center.
NOTE: The protocol workflow is divided into 4 parts as presented in Figure 1 and the required reagents are listed in the Table of Materials.
1. Bone Marrow (BM) Isolation
NOTE: MLL-AF9 leukemia mice we...

<ol>
	<li>Dr&#246;se, S., Brandt, U. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+mechanisms+of+superoxide+production+by+the+mitochondrial+respiratory+chain.">Molecular mechanisms of superoxide production by the mitochondrial respiratory chain.</a> Advances in experimental medicine and biology. 748, 145-169 (2012).</li><li>Gerber, P. A., Rutter, G. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+Role+of+Oxidative+Stress+and+Hypoxia+in+Pancreatic+Beta-Cell+Dysfunction+in+Diabetes+Mellitus.">The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus.</a> Antioxidant &amp; Redox Signaling. 26 (10), 501-518 (2017).</li><li>H&#246;hn, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Happily+(n)ever+after:+Aging+in+the+context+of+oxidative+stress,+proteostasis+loss+and+cellular+senescence.">Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence.</a> Redox Biology. 11, 482-501 (2017).</li><li>Reuter, S., Gupta, S. C., Chaturvedi, M. M., Aggarwal, B. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Oxidative+stress,+inflammation,+and+cancer:+how+are+they+linked.">Oxidative stress, inflammation, and cancer: how are they linked.</a> Free Radical Biology &amp; Medicine. 49 (11), 1603-1616 (2010).</li><li>Lee, B. W. L., Ghode, P., Ong, D. S. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Redox+regulation+of+cell+state+and+fate.">Redox regulation of cell state and fate.</a> Redox Biology. 2213-2317 (18), 30899 (2018).</li><li>Harris, J. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Glucose+metabolism+impacts+the+spatiotemporal+onset+and+magnitude+of+HSC+induction+in+vivo.">Glucose metabolism impacts the spatiotemporal onset and magnitude of HSC induction in vivo.</a> Blood. 121, 2483-2493 (2013).</li><li>Hole, P. S., Darley, R. L., Tonks, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Do+reactive+oxygen+species+play+a+role+in+myeloid+leukemias.">Do reactive oxygen species play a role in myeloid leukemias.</a> Blood. 117, 5816-5826 (2011).</li><li>Lagadinou, E. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=BCL-2+inhibition+targets+oxidative+phosphorylation+and+selectively+eradicates+quiescent+human+leukemia+stem+cells.">BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.</a> Cell Stem Cell. 12 (3), 329-341 (2013).</li><li>Di Marcantonio, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protein+Kinase+C+Epsilon+Is+a+Key+Regulator+of+Mitochondrial+Redox+Homeostasis+in+Acute+Myeloid+Leukemia.">Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.</a> Clinical Cancer Research. 24 (3), 608-618 (2018).</li><li>Glasauer, A., Chandel, N. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeting+antioxidants+for+cancer+therapy.">Targeting antioxidants for cancer therapy.</a> Biochemical Pharmacology. 92 (1), 90-101 (2014).</li><li>Krivtsov, A. V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transformation+from+committed+progenitor+to+leukaemia+stem+cell+initiated+by+MLL-AF9.">Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.</a> Nature. 442 (7104), 818-822 (2006).</li><li>Frascoli, M., Proietti, M., Grassi, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Phenotypic+analysis+and+isolation+of+murine+hematopoietic+stem+cells+and+lineage-committed+progenitors.">Phenotypic analysis and isolation of murine hematopoietic stem cells and lineage-committed progenitors.</a> Journal of Visualized Experiments. (65), (2012).</li><li>Lo Celso, C., Scadden, D. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Isolation+and+transplantation+of+hematopoietic+stem+cells+(HSCs).">Isolation and transplantation of hematopoietic stem cells (HSCs).</a> Journal of Visualized Experiments. (157), (2007).</li><li>Kalaitzidis, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=mTOR+complex+1+plays+critical+roles+in+hematopoiesis+and+Pten-loss-evoked+leukemogenesis.">mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis.</a> Cell Stem Cell. 11 (3), 429-439 (2012).</li><li>Sykes, S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=AKT/FOXO+signaling+enforces+reversible+differentiation+blockade+in+myeloid+leukemias.">AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.</a> Cell. 146 (5), 697-708 (2011).</li><li>Kalaitzidis, D., Neel, B. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Flow-cytometric+phosphoprotein+analysis+reveals+agonist+and+temporal+differences+in+responses+of+murine+hematopoietic+stem/progenitor+cells.">Flow-cytometric phosphoprotein analysis reveals agonist and temporal differences in responses of murine hematopoietic stem/progenitor cells.</a> PLoS One. 3 (11), 3776 (2008).</li><li>Kiel, M. J., Yilmaz, O. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., Morrison, S. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=SLAM+family+receptors+distinguish+hematopoietic+stem+and+progenitor+cells+and+reveal+endothelial+niches+for+stem+cells.">SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.</a> Cell. 121 (7), 1109-1121 (2005).</li><li>Mooney, C. J., Cunningham, A., Tsapogas, P., Toellner, K. M., Brown, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Selective+expression+of+flt3+within+the+mouse+hematopoietic+stem+cell+compartment.">Selective expression of flt3 within the mouse hematopoietic stem cell compartment.</a> International Journal Molecular Sciences. 18 (5), (2017).</li><li>Oguro, H., Ding, L., Morrison, S. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=SLAM+family+markers+resolve+functional+distinct+sub-populations+of+hematopoietic+stem+cells+and+multipotent+progenitors.">SLAM family markers resolve functional distinct sub-populations of hematopoietic stem cells and multipotent progenitors.</a> Cell Stem Cell. 13 (1), 102-116 (2013).</li><li>Osawa, M., Hanada, K., Hamada, H., Nakauchi, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Long-term+lymphohematopoietic+reconstitution+by+a+single+CD34-low/negative+hematopoietic+stem+cell.">Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell.</a> Science. 273 (5272), 242-245 (1996).</li><li>Morita, Y., Ema, H., Nakauchi, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Heterogeneity+and+hierarchy+within+the+most+primitive+hematopoietic+stem+cell+compartment.">Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment.</a> Journal of Experimental Medicine. 207 (6), 1173-1178 (2010).</li><li>Mukhopadhyay, P., Rajesh, M., Hask&#243;, G., Hawkins, B. J., Madesh, M., Pacher, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Simultaneous+detection+of+apoptosis+and+mitochondrial+superoxide+production+in+live+cells+by+flow+cytometry+and+confocal+microscopy.">Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy.</a> Nature Protocols. 2 (9), 2295-2301 (2007).</li><li>Camargo, F. D., Chambers, S. M., Drew, E., McNagny, K. M., Goodell, M. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hematopoietic+stem+cells+do+not+engraft+with+absolute+efficiencies.">Hematopoietic stem cells do not engraft with absolute efficiencies.</a> Blood. 107 (2), 501-507 (2006).</li><li>Morita, Y., Ema, H., Yamazaki, S., Nakauchi, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Non-side-population+hematopoietic+stem+cells+in+mouse+bone+marrow.">Non-side-population hematopoietic stem cells in mouse bone marrow.</a> Blood. 108 (8), 2850-2856 (2006).</li><li>de Almeida, M. J., Luchsinger, L. L., Corrigan, D. J., Williams, L. J., Snoeck, H. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dye-Independent+Methods+Reveal+Elevated+Mitochondrial+Mass+in+Hematopoietic+Stem+Cells.">Dye-Independent Methods Reveal Elevated Mitochondrial Mass in Hematopoietic Stem Cells.</a> Cell Stem Cell. 21 (6), 725-729 (2017).</li><li>Bonora, M., Ito, K., Morganti, C., Pinton, P., Ito, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Membrane-potential+compensation+reveals+mitochondrial+volume+expansion+during+HSC+commitment.">Membrane-potential compensation reveals mitochondrial volume expansion during HSC commitment.</a> Experimental Hematology. 68, 30-37 (2018).</li><li>Somervaille, T. C., Cleary, M. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Identification+and+characterization+of+leukemia+stem+cells+in+murine+MLL-AF9+acute+myeloid+leukemia.">Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.</a> Cancer Cell. 10 (4), 257-268 (2006).</li><li>Hao, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Metabolic+Imaging+Reveals+a+Unique+Preference+of+Symmetric+Cell+Division+and+Homing+of+Leukemia-Initiating+Cells+in+an+Endosteal+Niche.">Metabolic Imaging Reveals a Unique Preference of Symmetric Cell Division and Homing of Leukemia-Initiating Cells in an Endosteal Niche.</a> Cell Metabolism. 29 (4), 950-965 (2019).</li></ol>

The authors have nothing to disclose.

Fluorogenic dyes that have been developed for the detection of ROS are frequently evaluated in fixed cells by microscopy or in live cells by flow cytometry22. Flow cytometric evaluation of mitochondrial ROS in BM cells using mitochondrial ROS fluorogenic dyes has two major advantages: 1) It is a fast and simple technique that is suitable for live cell analysis and 2) it allows for distinguishing and analyzing rare populations at the single-cell level in the BM using surface marker staining. The st...

Reactive Oxygen Species (ROS) are highly reactive molecules derived from molecular oxygen. The most well-defined cellular location of ROS production is the mitochondria, where electrons that pass through the electron transport chain (ETC) during oxidative phosphorylation (OXPHOS) are absorbed by molecular oxygen leading to the formation of a specific type of ROS called superoxides1. Through the actions of a series of enzymes, called superoxide dismutases or SODs, superoxides are converted into hydrogen peroxides, which are subsequently neutralized into water by enzymes such as catalase or glutathione peroxidases (GPX). Perturbations in ROS-regulatory mechanisms can lead to the excess production of ROS, often referred to as oxidative stress, which have harmful and potentially lethal cellular consequences such as macromolecule damage (i.e., DNA, protein, lipids). Moreover, oxidative stress is related to several pathologies, such as diabetes, inflammatory diseases, aging and tumors2,3,4. To maintain redox homeostasis and prevent oxidative stress, cells possess a variety of ROS-regulating mechanisms5.
Physiological levels of certain ROS are necessary for proper embryonic and adult hematopoiesis6. However, excess ROS is associated with DNA damage, cellular differentiation and exhaustion of the hematopoietic stem and progenitor pool. There is also evidence that alterations in redox biology may differ between leukemia and healthy cells. For example, ROS levels tend to be higher in acute myeloid leukemia (AML) cells relative to their healthy counterparts and other studies have suggested that leukemia stem cells maintain a low steady-state level of ROS for survival7,8. Importantly, strategies for therapeutically capitalizing on these redox differences have shown promise in several human cancer settings9,10. Therefore, assays that allow for the assessment of ROS levels in mouse models may improve our understanding of how these species contribute to cellular physiology and disease pathogenesis as well as potentially provide a platform for assessing the effectiveness of novel redox-targeting anti-cancer therapies.

<table border="0" cellpadding="0" cellspacing="0" style="width:1109px;" width="1110">
	<colgroup>
		<col />
		<col />
		<col />
		<col />
	</colgroup>
	<tbody>
		<tr height="40">
			<td height="40" style="height:40px;width:247px;">Heat inactivated FBS</td>
			<td style="width:279px;">VWR Seradigm LIFE SCIENCE</td>
			<td style="width:393px;">97068-085</td>
			<td style="width:191px;">Media</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Penicillin Streptomycin</td>
			<td>Corning</td>
			<td>30-002-CI</td>
			<td>Media</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">PBS</td>
			<td>Fisher Scientific</td>
			<td>BP399-20</td>
			<td>Buffer</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">15 mL conical tube</td>
			<td>BD falcon</td>
			<td>352096</td>
			<td>Tissue Culture Supplies</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">50 mL conical tube</td>
			<td>BD falcon</td>
			<td>352098</td>
			<td>Tissue Culture Supplies</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">40 &#956;m cell strainers</td>
			<td>Fisher Scientific</td>
			<td>22-363-547</td>
			<td>Tissue Culture Supplies</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">RBC Lysis Buffer</td>
			<td>Fisher Scientific</td>
			<td>50-112-9751</td>
			<td>Tissue Culture Supplies</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Menadione sodium Bisulfite</td>
			<td>Sigma aldrich</td>
			<td>M5750</td>
			<td>Pro-oxidant</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">NAC</td>
			<td>Sigma aldrich</td>
			<td>A7250</td>
			<td>Anti-oxidant</td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:247px;">CD3 PE-Cy5 clone 145-2c11</td>
			<td>Biolegend</td>
			<td>100310</td>
			<td>Antibody</td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:247px;">CD4 PE-Cy5 clone RM4-5</td>
			<td>eBioscience</td>
			<td>15-0041-81</td>
			<td>Antibody</td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:247px;">CD8 PE-Cy5 clone 53-6.7</td>
			<td>eBioscience</td>
			<td>15-0081-81</td>
			<td>Antibody</td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:247px;">CD19 PE-Cy5 clone 6D5</td>
			<td>Biolegend</td>
			<td>115510</td>
			<td>Antibody</td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:247px;">B220 PE-Cy5 clone RA3-6B2</td>
			<td>Biolegend</td>
			<td>103210</td>
			<td>Antibody</td>
		</tr>
		<tr height="42">
			<td height="42" style="height:42px;width:247px;">Gr1 PE-Cy5 clone RB6-8C5</td>
			<td>Biolegend</td>
			<td>108410</td>
			<td>Antibody</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Ter119 PE-Cy5 clone Ter-119</td>
			<td>Biolegend</td>
			<td>116210</td>
			<td>Antibody</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">CD48 PE-Cy5 clone HM48-1</td>
			<td>Biolegend</td>
			<td>103420</td>
			<td>Antibody</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">CD117&#160; APC-Cy7 clone 2B8</td>
			<td>Biolegend</td>
			<td>105825</td>
			<td>Antibody</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Sca1 peacific Blue clone D7</td>
			<td>Biolegend</td>
			<td>108120</td>
			<td>Antibody</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">CD150 APC clone TC15-12F12.2</td>
			<td>Biolegend</td>
			<td>115909</td>
			<td>Antibody</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">CD34 FITC clone RAM34</td>
			<td>BD Bioscience</td>
			<td>553733</td>
			<td>Antibody</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">CD45.2 APC clone 104</td>
			<td>Biolegend</td>
			<td>1098313</td>
			<td>Antibody</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">MitoSOX Red</td>
			<td>ThermoFisher Scientific</td>
			<td>M36008</td>
			<td>Dye</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Mitotracker Green</td>
			<td>ThermoFisher Scientific</td>
			<td>M7514</td>
			<td>Dye</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Live/dead Yellow Dye</td>
			<td>ThermoFisher Scientific</td>
			<td>L34967</td>
			<td>Dye</td>
		</tr>
	</tbody>
</table>

flow cytometric analysis of mitochondrial reactive oxygen species in murine hematopoietic stem and progenitor cells and mll-af9 driven leukemia

We present a flow cytometric approach for analyzing mitochondrial ROS in various live bone marrow (BM)-derived stem and progenitor cell populations from healthy mice as well as mice with AML driven by MLL-AF9. Specifically, we describe a two-step cell staining process, whereby healthy or leukemia BM cells are first stained with a fluorogenic dye that detects mitochondrial superoxides, followed by staining with fluorochrome-linked monoclonal antibodies that are used to distinguish various healthy and malignant hematopoietic progenitor populations. We also provide a strategy for acquiring and analyzing the samples by flow cytometry. The entire protocol can be carried out in a timeframe as short as 3-4 h. We also highlight the key variables to consider as well as the advantages and limitations of monitoring ROS production in the mitochondrial compartment of live hematopoietic and leukemia stem and progenitor subpopulations using fluorogenic dyes by flow cytometry. Furthermore, we present data that mitochondrial ROS abundance varies among distinct healthy HSPC sub-populations and leukemia progenitors and discuss the possible applications of this technique in hematologic research.

Presented is a method for analyzing ROS in the mitochondria of multiple healthy and MLL-AF9-expressing leukemia progenitor populations. Figure 1 displays a schematic view of the protocol workflow, which consists of 4 major steps: 1) BM isolation from mice; 2) Staining BM cells with a fluorogenic dye that recognizes mitochondrial ROS, particularly superoxides; 3) Surface marker antibody staining to delineate various healthy and leukemia hematopoietic populations; and 4) Flow cytometry acquisi...

Watch this Scientific Journal Video about Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia at JoVE.com

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

We describe a method for using multiparameter flow cytometry to detect mitochondrial reactive oxygen species (ROS) in murine healthy hematopoietic stem and progenitor cells (HSPCs) and leukemia cells from a mouse model of acute myeloid leukemia (AML) driven by MLL-AF9.

We present a flow cytometric approach for analyzing mitochondrial ROS in various live bone marrow (BM)-derived stem and progenitor cell populations from ...

Reactive oxygen species or ROS, are highly reactive oxygen species that are produced by cells, and influences their behavior. Though excess ROS can also cause widespread cellular havoc, and in severe cases, cell death. Thus, the maintenance of ROS homeostasis is of fundamental importance to cellular function and survival.The protocol presented here, focuses on measuring a specific type of ROS, that is generated by mitochondria, mainly as a metabolic by-product in live, normal, or healthy hematopoietic stem and progenitor cell populations, as well as in leukemia cells from the mouse model of blood cancer, Acute Myeloid Leukemia or AML. This protocol can also be used to evaluate how genetic manipulation, such as gene deletion or overexpression, impacts mitochondrial ROS in several healthy and malignant hematopoietic populations. And as a result, potentially provide insightful information about redux state and possibly the metabolism of the cells.This technique authorizes flow settle metric analysis of a protogenic probe to monitor mitochondrial ROS production in live healthy and malignant hematopoietic stem and progenitor sub-populations. This protocol is straightforward and can be completed in a few hours. Moreover, it is suitable for live cell analysis and allows for distinguishing and analyzing mitochondrial ROS in stem cell population in the bone marrow, using surface mark of staining.After collecting mononuclear bone marrow cells from wild tight mice and leukemic MLL-AF9 mice, according to the manuscript, aliquot 200 microliters of the cell suspension into each of nine single color control tubes. Aliquot the remaining cells into other experimental tubes, 200 microliters each. Then place into a centrifuge two experimental tubes containing bone marrow cells and leukemic cells respectively, and one control tube.Centrifuge at 300 times G for five minutes. Next, decant the supernatant, and re-suspend the cells in room temperature F-PBS with a live/dead cell stain, according to the manufacturer's instructions. Incubate on ice for 30 minutes.Afterwards, add 1 milliliter of room temperature F-PBS to the three live/dead stained tubes, and one single color control tube for mitochondrial ROS dye staining. Place the tubes into the centrifuge at 300 times G for five minutes at room temperature. Then, obtain a 5 millimolar mitochondrial ROS dye stock solution by re-suspending 50 micrograms of mitochondrial ROS dye in 13 microliters of DMSO.Then add 13 milliliters of room temperature F-PBS to the 13 microliter mitochondrial ROS dye to dilute to a final concentration of five micromolar. If necessary, add 13 microliters of 50 millimolar Verapamil to the solution to inhibit mitochondrial efflux pumps. Obtain the tubes from the centrifuge and aspirate off the wash of the live/dead cell stain.Add 200 microliters of F-PBS in the live/dead staining control and keep it in ice until ready to start the analysis. Add 200 microliters of the mitochondrial ROS dye stain containing Verapamil, to each experimental tube, as well as the mitochondrial ROS staining control tube. Vortex to mix and incubate for 10 minutes at 37 degrees Celsius in the dark.Then add 1 milliliter of room temperature F-PBS to the control and experimental tubes. Centrifuge five minutes at 300 times G at room temperature. Aspirate off the supernatent and wash the cells with an additional one milliliter of room temperature F-PBS.Centrifuge again for five minutes at 300 times G, at room temperature. First, prepare two antibody cocktails for healthy and leukemia bone marrow cells. Aspirate the supernatant from the experimental tube containing healthy bone marrow cells, and add 200 microliters of the antibody cocktail number one to the tube.Vortex to mix. Also prepare the single color control tubes by adding 200 microliters of F-PBS and one microliter of the corresponding antibody. Incubate for 60 minutes on ice in the dark.Aspirate the supernatant from the experimental tube containing leukemia bone marrow, and add 200 microliters of the antibody cocktail number two, to the tube. Vortex to mix. Incubate for 60 minutes on ice in the dark.After that, wash all the tubes with 1 milliliter of cold F-PBS and centrifuge for five minutes at 300 times G at room temperature. Re-suspend the cells in 500 microliters of cold F-PBS. Transfer the cell suspension into each flow cytometer tube with a 40 micrometer filter for excluding aggregates.First, insert one no stain control tube into the flow cytometry machine and start the acquisition to compensate the flow cytometry machine. Repeat for other control tubes. Afterwards, read the experimental tubes to set up the gates.To analyze the size and complexity of the cell population, first for healthy HSPC, set the forward scatter area and side scatter area plots populations. Press the Square Gate button, to gate out extraneous debris from the forward and side scatter plot. Then, on a forward scatter area and height plot, use a double discriminator to gate out doublets.Select live cells, lineage low cells, and the various healthy HSPC. For each population of interest, analyze the median fluorescence intensity of the TRPE channel in a histagram plot, to evaluate differences in the mitochondrial ROS signal. Repeat the same procedure of size analysis, gating and histogram plotting for leukemia populations.Bone marrow cells isolated from healthy mice were stained with a live/dead dye and a mitochondrial ROS dye, and subsequently stained with antibodies recognizing lineage markers:plus CD48, C-kit, Sca-1, CD34 and CD150. In addition, bone marrow cells from leukemia mice were also stained with CD45.2 to discriminate between MLL-AF9 leukemia cells from healthy recipient bone marrow cells stained with CD45.1. A comparison of mitochondrial ROS staining, between healthy CD48 negative LSK, and myeloid progenitors, shows that myeloid progenitors display significantly higher levels of mitochondrial ROS staining.Moreover, c-Kit high leukemia progenitors display significantly higher levels of mitochondrial ROS staining, compared to c-Kit intermediate low leukemia cells, healthy CD48 negative LSK and myeloid progenitors. C-Kit intermediate low leukemia cells, also displayed a significantly higher value compared to CD48 negative LSK cells, but not to myeloid progenitors. Mitochondrial ROS dyes are highly reactive and appropriate wash steps are needed to ensure that any excess of the dye has been removed before starting the following steps.There are several chemically distinct ROS fluorogenic dyes that can be used in this protocol, to achieve a bit of knowledge of the redux status in live hematopoietic cells. This technique has been extensively used in the literature, and may provide useful insights on the metabolic and signaling pathways that are differentially regulated in leukemia cells, if compared with their normal counterparts.

flow-cytometric-analysis-mitochondrial-reactive-oxygen-species-murine

Research

JoVE Journal

Cancer Research

7.1K Görüntüleme.  Fox Chase Cancer Center. Reaktif oksijen türleri veya ROS, hücreler tarafından üretilen son derece reaktif oksijen türleridir, ve davranışlarını etkiler. Aşırı ROS da yaygın hücresel hasara neden olabilir rağmen, ve ciddi durumlarda, hücre ölümü. Bu nedenle, ROS homeostaz Bakımı hücresel fonksiyon ve sağkalım için temel öneme sahiptir.Burada sunulan protokol, mitokondri tarafından üretilen belirli bir ROS türünü ölçmeye odaklanır, özellikle canlı, normal veya sağlıklı hem...